| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,647,155 | 1,530,460 | 1,428,205 | 1,371,268 | | Cost of Revenue | 383,045 | 329,414 | 321,531 | 300,183 | | | Gross Profit | 1,264,110 | 1,201,046 | 1,106,674 | 1,071,085 | | | Operating Expenses | | Research Development | 241,638 | 188,779 | 201,863 | 188,062 | | Selling General and Administrative | 261,411 | 203,951 | 193,665 | 189,189 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 761,061 | 808,316 | 711,146 | 693,834 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,923 | 4,158 | 19,038 | 3,637 | | Earnings Before Interest And Taxes | 773,984 | 812,474 | 732,553 | 699,631 | | Interest Expense | 18,484 | 16,671 | 2,871 | 2,951 | | Income Before Tax | 755,500 | 795,803 | 729,682 | 696,680 | | Income Tax Expense | 186,355 | 209,227 | 161,488 | 192,675 | | Minority Interest |
-
|
-
| 2,369 | 2,160 | | | | Net Income From Continuing Ops | 569,145 | 586,576 | 568,194 | 504,005 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 569,145 | 586,576 | 568,194 | 504,005 | | Preferred Stock And Other Adjustments | 2,253 | 2,536 |
-
|
-
| | | Net Income Applicable To Common Shares | $571,398 | $589,112 | $568,194 | $504,005 |
|
0.17% Nasdaq 
0.08%
Income Statement
